Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response

Agirre, X., Fontalba, A., Andreu, E.J., Odero, M.D., Larráyoz, M.J., Montiel, C. ORCID: 0000-0002-9144-8809, Calasanz, M.J., Fernández-Luna, J.L. and Prósper, F., 2003. Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response. Haematologica, 88 (12), pp. 1425-1426. ISSN 0390-6078

Full text not available from this repository.

Item Type:	Journal article
Publication Title:	Haematologica
Creators:	Agirre, X., Fontalba, A., Andreu, E.J., Odero, M.D., Larráyoz, M.J., Montiel, C., Calasanz, M.J., Fernández-Luna, J.L. and Prósper, F.
Publisher:	Fondazione Ferrata Storti
Date:	2003
Volume:	88
Number:	12
ISSN:	0390-6078
Divisions:	Schools > School of Science and Technology
Record created by:	EPrints Services
Date Added:	09 Oct 2015 10:32
Last Modified:	10 Sep 2019 08:25
URI:	https://irep.ntu.ac.uk/id/eprint/14456

Actions (login required)

Edit View

Views

Downloads